個人化精神病學市場（按類型、治療領域和地區）

Personalized Psychiatry Market, By Type, By Therapeutic Areas, By Region

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

個人化精神病學市場規模預計在 2025 年達到 50.8 億美元，預計到 2032 年將達到 107.5 億美元，2025 年至 2032 年的複合年成長率為 11.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	50.8億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	11.30%	2032年價值預測	107.5億美元

個人化精神病學是精神衛生保健領域的新興領域，旨在改變精神疾病的診斷和治療方式。傳統上，精神病學依賴「一刀切」的方法，即根據廣泛的診斷標準為患者開藥和治療方法。個人化精神病學利用每位患者特有的基因、生物和臨床數據，制定針對性的精神健康治療方案。個人化精神病學旨在以更有針對性的客製化策略取代「一刀切」的策略。所使用的一些關鍵技術包括穿戴式生物感測器、電腦化治療方案、定量腦電圖、藥物基因組學檢測和分子診斷。社會對心理健康問題認知的不斷提高、神經生物學和基因組學的發展以及對更好的心理健康診斷和治療結果的需求是推動市場發展的主要因素。

市場動態：

個人化精神病學市場預計將在未來幾年實現顯著成長，這主要得益於以下幾個關鍵因素：數位健康技術的快速發展、基因組學、穿戴式裝置和行動應用程式的創新。此外，心理健康評估和治療領域的人工智慧也有望在預測期內推動市場成長。這些技術能夠即時收集數據，使臨床醫生能夠遠端監控患者並做出明智的護理決策。

然而，個人化精神醫學市場也面臨許多挑戰。主要的限制因素之一是實施個人化治療方案的高成本。先進技術的開發和實施成本高昂，而且這些服務的報銷方案可能有限。此外，在精神健康保健中使用基因數位資料還存在監管和倫理問題，這可能會減緩個人化治療方案的推廣。

本研究的主要特點

本報告對全球個人化精神病學市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025 年至 2032 年的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球個人化精神病學市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球個人化精神病學市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球個人化精神病學市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 5.08 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.30%	2032 Value Projection:	USD 10.75 Bn

Personalized psychiatry is an emerging field within the realm of mental healthcare that aims to revolutionize the way mental illnesses are diagnosed and treated. Traditionally, psychiatry has relied on a one-size-fits-all approach, where patients are prescribed medications or therapies based on broad diagnostic criteria. Using individual patient-specific genetic, biological, and clinical data, personalized psychiatry creates specialized mental health treatments and therapies. It seeks to replace the one-size-fits-all strategy with a more focused, customized one. Among the important technologies utilized are wearable biosensors, computerized therapy programs, quantitative EEG, pharmacogenomic testing, and molecular diagnostics. Growing public awareness of mental health issues, developments in neurobiology and genomics, and the need for better mental health diagnosis and treatment outcomes are the primary factors propelling the market.

Market Dynamics:

The personalized psychiatry market is expected to witness significant growth in the coming years, driven by several key factors such as rapid advancement of digital health technologies, innovations in genomics, wearables, and mobile apps. In addition, artificial intelligence in the field of mental health assessment and treatment is also expected to drive market growth over the forecast period. These technologies enable the collection of real-time data, allowing clinicians to monitor patients remotely and make informed decisions about their care.

However, the personalized psychiatry market also faces some challenges. One of the main restraints is the high cost associated with implementing personalized approaches. Developing and deploying advanced technologies can be expensive, and there may be limited reimbursement options for these services. Furthermore, there are regulatory and ethical considerations surrounding the use of genetic and digital data in mental healthcare, which may slow down the adoption of personalized approaches.

Key features of the study:

This report provides in-depth analysis of the global personalized psychiatry market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized psychiatry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GreyBird Ventures, Sunovion Pharmaceuticals Inc., HMNC Holding GmbH, Arcara Personalized Psychiatry, Starling Minds, Karuna Therapeutics, CBT Plus, AltheaDx, Inc., WayForward, BrightQuest, Peak Mental Wellness
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized psychiatry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized psychiatry market

Detailed Segmentation:

By Type:
- Products
- Diagnostics
- Therapeutics
- Services
- Software
By Therapeutic Areas:
- Depression
- Anxiety
- Bipolar Disorder
- Schizophrenia
- Addiction
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GreyBird Ventures
- Sunovion Pharmaceuticals Inc.
- HMNC Holding GmbH
- Arcara Personalized Psychiatry
- Starling Minds
- Karuna Therapeutics
- CBT Plus
- AltheaDx, Inc.
- WayForward
- BrightQuest
- Peak Mental Wellness

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Personalized Psychiatry, By Type
- Market Personalized Psychiatry, By Therapeutic Areas
- Market Personalized Psychiatry, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing need for improved diagnosis and treatment outcomes in mental healthcare
- Rising prevalence of mental disorders
- Growing adoption of precision medicine model in healthcare
Restraints
Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Personalized Psychiatry Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Personalized Psychiatry Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diagnostics
Therapeutics
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Personalized Psychiatry Market, By Therapeutic Areas, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Anxiety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Bipolar Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Schizophrenia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Personalized Psychiatry Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

GreyBird Ventures
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sunovion Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HBNC Holding GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arcara Personalized Psychiatry
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Starling Minds
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Karuna Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CBT Plus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AltheaDx, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WayForward
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BrightQuest
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Peak Mental Wellness
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views